Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,734.00
Bid: 1,733.50
Ask: 1,734.00
Change: -12.50 (-0.72%)
Spread: 0.50 (0.029%)
Open: 1,748.50
High: 1,752.50
Low: 1,733.50
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Italian shares jump on Draghi hope; GSK weighs on FTSE 100

Wed, 03rd Feb 2021 09:18

* Milan stocks rise on hopes of Draghi becoming next PM

* Daimler jumps on plan to spin-off truck business

* GSK slides; warns of bigger than expected fall in 2021
earnings
(Updates to close)

By Shreyashi Sanyal and Susan Mathew

Feb 3 (Reuters) - Italian shares posted their best session
in four weeks on Wednesday after former European Central Bank
chief Mario Draghi accepted the task of forming a new
government, while a surge in German carmaker Daimler lifted an
index of broader European shares.

Milan's FTSE MIB index closed up 2.1%, while
Italy's 10-year bond yield tumbled.

Draghi said he was confident of securing sufficient backing
in parliament after President Sergio Mattarella sought his help
after hearing that efforts to salvage the collapsed coalition of
Prime Minister Giuseppe Conte had failed.

"It may not all be plain sailing and some uncertainties and
negotiations remain. But... markets like the news of well-known
central bankers at the helm of government," said Maria Paola
Toschi, global market strategist at J.P. Morgan Asset
Management.

"For the economy, avoiding lengthy further attempts to form
a government should mean that critical near-term issues can be
addressed."

Italy has been hit by the COVID-19 pandemic and economic
crises against the backdrop of political uncertainty battering
the country.

On the pan-European STOXX 600 index Daimler
was the top boost after unveiling plans to spin-off
its trucks business. It rose 8.9% while the broader index gained
0.3%.

Germany's DAX rose 0.7% to hit its highest in two
weeks.

London's blue-chip index slipped 0.1% as
GlaxoSmithKline slid 6.3% after it warned of a bigger
than expected fall in 2021 earnings as the COVID-19 pandemic
continues to disrupt other healthcare treatments.

But upbeat earnings from other companies helped push gains
on the pan-region index to a third straight day, with Novo
Nordisk, Siemens AG, Publicis Groupe SA
all rising after reporting results.

Drugmaker Argenx was the top gainer after it
raised $1 billion in capital increase.

Also keeping sentiment buoyed was hopes of U.S. stimulus
after the Senate took steps to allow Democrats to pass President
Joe Biden's proposed $1.9 trillion COVID-19 aid bill without
Republican support.

European stocks have been steadily rising along with other
major markets after losing more than 3% last week on concerns
around the slow roll-out of COVID-19 vaccines in the euro zone.

A pause in a social media driven rally that drove up prices
of silver as well as certain stocks including GameStop Corp
has helped calm worries about potential losses incurred
by certain hedge funds causing disruption to markets as a whole.
(Reporting by Shreyashi Sanyal in Bengaluru; Editing by Shounak
Dasgupta, Kirsten Donovan)

More News
Today 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
Today 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.